Hosted on MSN3h
For Your Patients: What Is Multiple Myeloma?
Although the cause of multiple myeloma is not known, research shows that genetic changes in the DNA of a single plasma cell ...
emjreviews.com6h
High-Risk Genetic Markers Predict Poor Outcomes in Multiple Myeloma
Study reveals multiple high-risk genetic changes predict worse multiple myeloma outcomes across all treatments.
Medpage Today on MSN12h
The Basics of Multiple Myeloma
In spite of recent advances in the management of multiple myeloma, cure has been elusive, with efforts to improve long-term ...
Armed robbery in Revesby5d
City of Hope Highlights Myeloma Study, Cancer Surgery
This roundup highlights a common drug that can help treat multiple myeloma, a paper analyzing the benefit of a colorectal surgery follow-up test ...
EurekAlert!5d
City of Hope research features myeloma study, cancer surgery and more
City of Hope® Research Spotlight offers a glimpse at groundbreaking scientific and clinical discoveries advancing lifesaving cures for patients with cancer, diabetes and other chronic, ...
CARsgen Therapeutics Introduced Zhuhai SB Xinchuang to Accelerate Allogeneic CAR-T Cell Products Development in Mainland China
CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK, "CARsgen Therapeutics"), a company focused on innovative CAR ...
PharmiWeb6d
Sarclisa approved in Japan for patients with newly diagnosed multiple myeloma
The Ministry of Health, Labour and Welfare (MHLW) in Japan has approved Sarclisa, in combination with bortezomib, lenalidomide, and dexamethasone (VRd), for the treatment of adult patients with newly ...